NCT06818552 The Role of the Vascular Surgeon in Orthopedic Surgery of Musculoskeletal Tumors
| NCT ID | NCT06818552 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Muscle Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 70 participants |
| Start Date | 2023-06-21 |
| Primary Completion | 2025-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 70 participants in total. It began in 2023-06-21 with a primary completion date of 2025-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Very large musculoskeletal tumors frequently involve vascular structures. Literature data show that spinal surgery and orthopedic surgery are the specialist branches that most frequently require intraoperative vascular surgical assistance, with 33.8% and 26.4% of requests, respectively6. In these cases, the surgical assistance of the vascular surgeon allows the safe removal of the mass, the possible repair of vessels damaged during cleavage and isolation of the mass, the ligation or complete reconstruction of the involved vascular segment and contributes to reducing intraoperative and postoperative complications7.
Eligibility Criteria
Inclusion Criteria: * Patient diagnosed with musculoskeletal tumor involving vascular structures requiring surgical removal * Planned surgical treatment with intraoperative assistance of the vascular surgeon * Obtaining informed consent * Age 18 years Exclusion Criteria: \-
Contact & Investigator
Mauro Gargiulo, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06818552 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Muscle Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06818552 currently recruiting?
Yes, NCT06818552 is actively recruiting participants. Contact the research team at mauro.gargiulo2@unibo.it for enrollment information.
Where is the NCT06818552 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06818552 clinical trial?
NCT06818552 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Mauro Gargiulo, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 70 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.